Nym

Aims to generate world-class investment returns over the long term in a way that makes our partners and portfolio companies proud, as they build a unique, global investment platform.

Addition is a venture capital firm that invests in early and growth-stage tech companies.

With more than 135 IPOs and 200 portfolio companies in the enterprise, consumer and healthcare spaces, Bessemer supports founders and CEOs from their early days through every stage of growth. Bessemer’s global portfolio has included Pinterest, Shopify, Twilio, Yelp, LinkedIn, PagerDuty, DocuSign, Wix, Fiverr and Toast and has more than $20 billion of assets under management.

mission is to invest in ambitious founders solving overlooked problems in the US, Israel, and Emerging Markets. In the last 3 years, with a significant increase in capital deployed per year and the portfolio growing to 77+ investments, returns have trended to the +95th percentile.

GP at GV, investing across healthcare delivery and neuropsychiatric therapeutics. As a psychiatrist by background, Ben also leads GV’s investments in mental health-related companies, including Headway and Brightline. His investments include Aspire (acquired by Anthem), Rodin (acquired by Alkermes), Carebridge, Patina, Waltz Health, Nym, and Cerevance.

Adam is widely regarded as one of the top investors in Israel with experience investing across the technology stack. Managing Bessemer’s Israel office since 2007, Adam has invested in more than 30 Israeli startups and several European startups, a third of which were pre-product at the time of his initial investment. With more than 21 M&A and IPO exits over his career, he has also been recognized as one of the top investors. Adam’s life experiences–like his investments–are uniquely global. Born in South Africa, Adam was raised and educated in the US, where he studied at the School of Foreign Service at Georgetown University. Before joining Bessemer, he spent nine years at Jerusalem Venture Partners, where he was a partner in their New York, Jerusalem, and Beijing offices.

Former co-founder, president and COO of both Flatiron Health (acquired by Roche in 2018 for $2b) and Invite Media (acquired by Google in 2010 for $81m). Invested in hundreds of technology startups throughout the country, including Bark, Clover Health, Color Genomics, Cometeer, Headway, Hyperscience, Imagen, Plaid, Oscar, RigUp, Ro and Spring Health.

CEO of Collectors Holdings, a holding company focused on the collectibles industry. Before Collectors Holdings, Nat was co-founder and CEO of Flatiron Health, a technology company focused on the oncology industry that was acquired by Roche in 2018. Nat remains Chairman of Flatiron Health. Before co-founding Flatiron Health, Nat was co-founder and CEO of Invite Media, an advertising technology company based in NYC. Invite Media built the industry’s first enterprise advertising platform for buying and optimizing online media in real-time. Invite Media was acquired by Google in 2010. An active angel investor since 2010, Nat has invested in over 250 startups, including BarkBox, Cedar, Clover Health, Color Genomics, Headway, Imagen, Immuta, Oscar, Philo, Plaid, Ribbon Health, Workrise, Vise, and Zipline.